A Look At Evolv Technologies (EVLV) Valuation After Renewed Phillies Security Partnership

Evolv Technologies Holdings (EVLV) drew fresh attention after renewing and expanding its partnership with the Philadelphia Phillies, keeping its Evolv Express systems at Citizens Bank Park and upgrading the hardware to newer Gen2 units.

See our latest analysis for Evolv Technologies Holdings.

The partnership renewal arrives after a volatile stretch for the stock, with the share price down 10.22% over the last month but up 23.51% over 90 days, while the 1 year total shareholder return is 20.26%.

If you are comparing Evolv with other AI focused security and infrastructure stories, it can help to widen the lens and scan 48 AI infrastructure stocks

Against that backdrop, Evolv now sits at US$6.41 per share, with a 1 year total return of 20.26% and a value score of 2. This raises the question of whether the stock is underappreciated or the market is already pricing in future growth.

Most Popular Narrative: 35.9% Undervalued

With Evolv Technologies Holdings last closing at $6.41 and the most followed fair value estimate at $10.00, the gap between market price and narrative expectations is clear and sizable.

The increasing prevalence of large multi-year contracts with public school systems and hospitals driven by heightened public safety concerns in high-density environments is expanding Evolv's total addressable market and should support outsized revenue growth over the coming years.

Read the complete narrative. Read the complete narrative.

Want to understand why this valuation leans so far above the current share price? The core of the narrative rests on compounded revenue expectations, a step change in profit margins and a rich future earnings multiple that is usually reserved for market favorites. Curious which specific growth path and profitability shift underpin that $10.00 figure and the implied upside over today’s $6.41 level? The full narrative lays out the numbers behind that story.

Result: Fair Value of $10.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this story still carries real execution risk, particularly around customer concentration and litigation or regulatory issues that could unsettle margins and long term earnings visibility.

Find out about the key risks to this Evolv Technologies Holdings narrative.

Another View: Pricing Signals A Richer Story

The fair value narrative points to Evolv as 35.9% undervalued, yet the current P/S ratio of 7.2x tells a more cautious story. It is roughly double the US Electronic industry at 3.3x and also above the 3.5x fair ratio, even though it sits below peer averages at 8.7x.

For you, that means the stock already carries a premium that could compress if expectations cool, or hold if revenue and margins track the more optimistic script. The key question is which scenario feels closer to how you see this business playing out.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With both risks and rewards in play, the real question is how you weigh them. Take a close look at the data and form your own stance by checking out the 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you could miss opportunities that fit your style even better, so use the screener to pressure test your next moves.

• Target stronger value potential by scanning 47 high quality undervalued stocks that pair quality fundamentals with prices the market may not fully appreciate yet.
• Prioritise resilience by focusing on 63 resilient stocks with low risk scores that aim to keep downside in check while still giving you room for upside.
• Hunt for tomorrow’s standouts before the crowd catches on by reviewing the screener containing 22 high quality undiscovered gems tucked away off most investors’ radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com